Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial

[1] Regidor DL(2006)Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients J Am Soc Nephrol 17 1181-91

[2] Kopple JD(2002)Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the third National Health and Nutrition examination survey J Am Soc Nephrol 13 504-10

[3] Kovesdy CP(1999)Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin Am J Kidney Dis 34 125-34

[4] Kilpatrick RD(1987)Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial N Engl J Med 316 73-78

[5] McAllister CJ(1989)Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously BMJ 299 157-58

[6] Aronovitz J(1996)Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis Am J Kidney Dis 27 234-8

[7] Greenland S(1995)R-HuEPO hyporesponsiveness—who and why? Nephrol Dial Transplant 10 S69-S73

[8] Kalantar-Zadeh K(2002)Iron status and hemoglobin level in chronic renal insufficiency J Am Soc Nephrol 13 2783-6

[9] Hsu CY(2006)Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron J Nephrol 19 161-7

[10] McCulloch CE(2001)Iron biology in immune function, muscle metabolism and neuronal functioning J Nutrition 131 568S-580S

[1] Regidor DL(2006)Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients J Am Soc Nephrol 17 1181-91

[2] Kopple JD(2002)Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the third National Health and Nutrition examination survey J Am Soc Nephrol 13 504-10

[3] Kovesdy CP(1999)Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin Am J Kidney Dis 34 125-34

[4] Kilpatrick RD(1987)Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial N Engl J Med 316 73-78

[5] McAllister CJ(1989)Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously BMJ 299 157-58

[6] Aronovitz J(1996)Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis Am J Kidney Dis 27 234-8

[7] Greenland S(1995)R-HuEPO hyporesponsiveness—who and why? Nephrol Dial Transplant 10 S69-S73

[8] Kalantar-Zadeh K(2002)Iron status and hemoglobin level in chronic renal insufficiency J Am Soc Nephrol 13 2783-6

[9] Hsu CY(2006)Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron J Nephrol 19 161-7

[10] McCulloch CE(2001)Iron biology in immune function, muscle metabolism and neuronal functioning J Nutrition 131 568S-580S